Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Quimioterapia para la neoplasia trofoblástica gestacional resistente o recidivante

Esta versión no es la más reciente

ver la versión actual 13 enero 2016

Información

DOI:
https://doi.org/10.1002/14651858.CD008891.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 12 diciembre 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Cáncer ginecológico, neurooncología y otros cánceres

Copyright:
  1. Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Mo'iad Alazzam

    Correspondencia a: Department of Gynaecology, The Galway Clinic, Doughiska, Ireland

    [email protected]

    [email protected]

  • John Tidy

    Obstetrics & Gynaecology, Sheffield Teaching Hospitals Foundation NHS Trust, Sheffield, UK

  • Raymond Osborne

    Division of Gynecology‐Oncology, Toronto‐Sunnybrook Regional Cancer Centre, Toronto, Canada

  • Robert Coleman

    School of Medicine and Biomedical Sciences, Sheffield University, Sheffield, UK

  • Barry W Hancock

    School of Medicine and Biomedical Sciences, Sheffield University, Sheffield, UK

  • Theresa A Lawrie

    Cochrane Gynaecological Cancer Group, Royal United Hospital, Bath, UK

Contributions of authors

MA conceived the idea, registered the title and wrote the first draft of the protocol. JT helped to write the protocol. MA and TL wrote the first draft of the review. BH, RO and RC critically appraised the manuscript. All the authors approved the final draft.

Sources of support

Internal sources

  • No sources of support supplied

External sources

  • National Institute for Health Research (NIHR), UK.

    This review received methodological and statistical support as part of the 10/4001/12 NIHR Cochrane Programme Grant Scheme ‐ Optimising care, diagnosis and treatment pathways to ensure cost effectiveness and best practice in gynaecological cancer: improving evidence for the NHS.

Declarations of interest

All the authors have no interest to declare.

Acknowledgements

The authors would like to thank Alison Little (Sheffield University, UK) and Jane Hayes (Cochrane Gynaecological Cancer Review Group (CGCRG), Bath, UK) for developing the search strategies and performing the searches; Jo Morrison (CGCRG Co‐ordinating Editor), Clare Jess and Gail Quinn (CGCRG Managing Editors) for their support and administrative help; and the library staff at the Royal United Hospital (Bath, UK) for the sourcing of many articles.

Version history

Published

Title

Stage

Authors

Version

2016 Jan 13

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Review

Mo'iad Alazzam, John Tidy, Raymond Osborne, Robert Coleman, Barry W Hancock, Theresa A Lawrie

https://doi.org/10.1002/14651858.CD008891.pub3

2012 Dec 12

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Review

Mo'iad Alazzam, John Tidy, Raymond Osborne, Robert Coleman, Barry W Hancock, Theresa A Lawrie

https://doi.org/10.1002/14651858.CD008891.pub2

2010 Dec 08

Chemotherapy for resistant or recurrent gestational trophoblastic neoplasia

Protocol

Mo'iad Alazzam, John Tidy, Raymond Osborne, Robert Coleman, Barry W Hancock

https://doi.org/10.1002/14651858.CD008891

Differences between protocol and review

None.

PICO

Population
Intervention
Comparison
Outcome

El uso y la enseñanza del modelo PICO están muy extendidos en el ámbito de la atención sanitaria basada en la evidencia para formular preguntas y estrategias de búsqueda y para caracterizar estudios o metanálisis clínicos. PICO son las siglas en inglés de cuatro posibles componentes de una pregunta de investigación: paciente, población o problema; intervención; comparación; desenlace (outcome).

Para saber más sobre el uso del modelo PICO, puede consultar el Manual Cochrane.